FIELD: medicine.
SUBSTANCE: method includes introduction of metabolitotropic cardioprotector represented by (S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate in a dose of 100 mg/kg a day for 30 days. Invention application allows to increase therapeutic efficiency due to cardioprotective activity and low toxicity of (S)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate.
EFFECT: increased efficiency of treatment.
2 tbl,1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-METHYL-1,2,4-TRIAZOLE-5-THIOACETATE (S) -2,6-DIAMINOHEXANE ACID APPLICATION AS ACTIVE DRUG BASE FOR PREVENTION AND TREATMENT OF CNS VITAL FUNCTIONS IN CASE OF SEVERE FORMS OF ACUTE ETHANOL POISONING | 2016 |
|
RU2613875C1 |
| METHOD FOR CORRECTING NEUROLOGICAL DISTURBANCES ACCOMPANYING ALCOHOL INTOXICATION | 2014 |
|
RU2561063C1 |
| METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
| APPLICATION OF L-LYSINE TIAZOTOTATE AS AN ACTIVE BASIS FOR MEDICINES OF HEPATOPROTECTIVE AND DETOXICATIVE ACTION | 2018 |
|
RU2679447C1 |
| HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
| 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (MT) | 2008 |
|
RU2404974C2 |
| LYSINIUM 3-METHYL-1,2,4-TRIASOLYL-5-THIOACETATE WITH NEUROPROTECTIVE, NOOTROPIC, CARDIOPROTECTIVE, ENDOTHELIOTROPIC, ANTI-ISCHEMIC, ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTIHYPOXIC EFFECT AND LOW TOXICITY | 2007 |
|
RU2370492C2 |
| USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS | 2013 |
|
RU2532394C1 |
| METHOD FOR PREPARING (S)-2,6-DIAMINOHEXANE ACID 3-METHYL-1,2,4-TRIAZOLYL-5-THIOACETATE | 2012 |
|
RU2495874C1 |
| DRUG PREPARATION WITH CARDIOPROTECTIVE ACTIVITY | 2010 |
|
RU2476224C2 |
